76 related articles for article (PubMed ID: 17483304)
41. The RAD51 gene family, genetic instability and cancer.
Thacker J
Cancer Lett; 2005 Mar; 219(2):125-35. PubMed ID: 15723711
[TBL] [Abstract][Full Text] [Related]
42. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.
Barwell J; Pangon L; Hodgson S; Georgiou A; Kesterton I; Slade T; Taylor M; Payne SJ; Brinkman H; Smythe J; Sebire NJ; Solomon E; Docherty Z; Camplejohn R; Homfray T; Morris JR
J Med Genet; 2007 Aug; 44(8):516-20. PubMed ID: 17483304
[TBL] [Abstract][Full Text] [Related]
43. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
44. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
46. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
Worrillow LJ; Allan JM
Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
[TBL] [Abstract][Full Text] [Related]
47. The Fanconi Anemia/BRCA pathway: new faces in the crowd.
Kennedy RD; D'Andrea AD
Genes Dev; 2005 Dec; 19(24):2925-40. PubMed ID: 16357213
[TBL] [Abstract][Full Text] [Related]
48. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6.
Ostergaard JR; Sunde L; Okkels H
Am J Med Genet A; 2005 Dec; 139A(2):96-105; discussion 96. PubMed ID: 16283678
[TBL] [Abstract][Full Text] [Related]
49. Nonsense-mediated mRNA decay in mammals.
Maquat LE
J Cell Sci; 2005 May; 118(Pt 9):1773-6. PubMed ID: 15860725
[No Abstract] [Full Text] [Related]
50. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
51. Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer.
Plevová P; Sedláková E; Zapletalová J; Krepelová A; Skýpalová P; Kolár Z
Virchows Arch; 2005 Feb; 446(2):112-9. PubMed ID: 15735976
[TBL] [Abstract][Full Text] [Related]
52. Mismatch repair and DNA damage signalling.
Stojic L; Brun R; Jiricny J
DNA Repair (Amst); 2004; 3(8-9):1091-101. PubMed ID: 15279797
[TBL] [Abstract][Full Text] [Related]
53. GeneNote: whole genome expression profiles in normal human tissues.
Shmueli O; Horn-Saban S; Chalifa-Caspi V; Shmoish M; Ophir R; Benjamin-Rodrig H; Safran M; Domany E; Lancet D
C R Biol; 2003; 326(10-11):1067-72. PubMed ID: 14744114
[TBL] [Abstract][Full Text] [Related]
54. Mismatch repair and response to DNA-damaging antitumour therapies.
Bignami M; Casorelli I; Karran P
Eur J Cancer; 2003 Oct; 39(15):2142-9. PubMed ID: 14522371
[TBL] [Abstract][Full Text] [Related]
55. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
